Epigenomics AG Stock price Deutsche Boerse AG
Equities
ECX
DE000A11QW50
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 EUR | -1.92% | +9.51% | -4.03% |
Sales 2024 * | 150K 162K | Sales 2025 * | - | Capitalization | 1.62M 1.74M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | -3.47 x |
Net cash position 2024 * | 2.14M 2.3M | Net cash position 2025 * | 1.69M 1.82M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.77
x | P/E ratio 2025 * |
-2.79
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.43% |
1 day | -1.92% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.65% | 12.54B | |
+82.29% | 4.14B | |
-14.23% | 2.34B | |
-23.73% | 2.51B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+7.42% | 840M | |
-11.75% | 548M | |
-34.49% | 466M |
- Stock
- Equities
- Stock Epigenomics AG
- Stock Epigenomics AG - Deutsche Boerse AG